400-859-2883
Current Location:Home > API
More PEG Derivatives  |   Pharma Intermediates  |   API  |   Vaccine Excipients  |   Chemical Reagents  |  

API

Fluralaner

Fluralaner
User Evaluation Collection Products
Synonyms
4-(5-(3,5-Dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-2-methyl-N-(2-oxo-2-(2,2,2-trifluoroethylamino)ethyl)benzamide;4-[5-(3,5-Dichlorophenyl)-5-(Trifluoromethyl)-4H-1,2-Oxazol-3-Yl]-2-Methyl-N-[2-Oxo-2-(2,2,2-Trifluoroethylamino)Ethyl]Benzamide
Catalog ID
101054
CAS NO.
864731-61-3
Purity
95%
MDL Number
MFCD30533410
EINECS
Molecular formula
C22H17Cl2F6N3O3
Molecular weight
556.288
Please be kindly noted that our product can only be used for research to organizations or companies and we don't cooperate with personal buyers.

Huateng Pharma, a global supplier of pharmaceutical intermediates, PEG derivatives and other chemical products, offers CAS NO.864731-61-3 for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation.

Application: Fluralaner (CAS NO.864731-61-3) is a systemic insecticide and acaricide that is administered orally. The US Food and Drug Administration (FDA) approved it under the trade name Bravecto for flea treatment in dogs or cats in May 2014. The EU approved the drug in February 2014.

I want to comment